Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc (NYSE: PFE) provided an update on the apixaban clinical development program. The companies announced that new Phase II data in acute coronary s
read more »
Add this link to...
Bury
Add to:
| Bookmarks
One of pharmacology's oldest underlying principles looks set to be overturned. New findings from chemists at the UK's University of Warwick appear to contradict the century-old 'Overton's Rule',
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Lundbeck's partner Teva Pharmaceutical Industries Ltd. has announced that results of the phase III ADAGIO trial were presented during the 12th Congress of European Federation of Neurological Societi
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Inspection Found Sandoz Failed To Properly Validate Manufacturing Process For Metoprolol Succinate ER Tablets (Generic Form Of Toprol XL) Before Distributing Pills
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Genzyme Corp. (Nasdaq: GENZ), a global leader in biotechnology, and Medicines for Malaria Venture (MMV), a not-for-profit virtual research and development (R&D) organization dedicated to reducing the
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Alpharma, Inc. (NYSE: ALO), a global specialty pharmaceutical company, confirmed that it received an unsolicited, non-binding proposal from King Pharmaceuticals, Inc. (NYSE: KG) to acquire all of the
read more »
Add this link to...
Bury
Add to:
| Bookmarks
King Pharmaceuticals, Inc. (NYSE: KG) announced that it has submitted to the Board of Directors of Alpharma Inc. (NYSE: ALO) a proposal to acquire all of the outstanding shares of common stock of Alp
read more »
Add this link to...
Bury
Add to:
| Bookmarks
The U.S. Food and Drug Administration approved Nplate (romiplostim), the first product that directly stimulates the bone marrow to produce needed platelets in patients with a rare blood disorder that
read more »
Add this link to...
Bury
Add to:
| Bookmarks